NX-13 is a novel oral small molecule NLRX1 agonist, which can increase oxidative phosphorylation in immune cells, decrease the differentiation of effector CD4+ T cells, and reduce the production of inflammatory cytokines in the gastrointestinal tract through activation of the NLRX1 pathway, and can be used in studies related to ulcerative colitis (UC).
Molecular Weight:
399.44
Purity:
>98.0%
CAS Number:
[2389235-01-0]
Formula:
C24H21N3O3
Target:
NLR
* VAT and and shipping costs not included. Errors and price changes excepted
